Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PYGB | P11216 | 1/20 | 0.39 |
| ▸ | LGALS3 | P17931 | 3/20 | 0.35 |
| ▸ | LGALS8 | O00214 | 3/20 | 0.35 |
| ▸ | LGALS1 | P09382 | 2/20 | 0.35 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.35 |
| ▸ | FBP1 | P09467 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | OGA | O60502 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15890528 | 1.00 | PYGB (0.39) | PYGBLGALS3LGALS8LGALS1LGALS9 | |
| SCHEMBL15472865 | 1.00 | PYGB (0.39) | PYGBLGALS3LGALS8LGALS1LGALS9 | |
| SCHEMBL20692159 | 0.90 | PYGB (0.46) | PYGBLGALS3LGALS8LGALS1LGALS9 | |
| SCHEMBL5019779 | 0.90 | PYGB (0.46) | PYGBLGALS3LGALS8LGALS1LGALS9 | |
| SCHEMBL15343514 | 0.90 | PYGB (0.46) | PYGBLGALS3LGALS8LGALS1LGALS9 | |
| SCHEMBL14465071 | 0.90 | PYGB (0.46) | PYGBLGALS3LGALS8LGALS1LGALS9 | |
| SCHEMBL14274191 | 0.90 | PYGB (0.46) | PYGBLGALS3LGALS8LGALS1LGALS9 | |
| SCHEMBL13768389 | 0.88 | PYGB (0.49) | PYGBLGALS3LGALS8LGALS1LGALS9 | |
| SCHEMBL19255671 | 0.88 | PYGB (0.49) | PYGBLGALS3LGALS8LGALS1LGALS9 | |
| SCHEMBL14306795 | 0.88 | PYGB (0.49) | PYGBLGALS3LGALS8LGALS1LGALS9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10034851-B2 | Metal-salen complex compound, local anesthetic and antineoplastic drug | IHI CORPORATION (JP) | 2018-07-31 | — | — | US | disclosed |
| US-9505732-B2 | Auto magnetic metal salen complex compound | IHI CORPORATION (JP) | 2016-11-29 | — | — | US | disclosed |
| US-20160263074-A1 | METAL-SALEN COMPLEX COMPOUND, LOCAL ANESTHETIC AND ANTINEOPLASTIC DRUG | ISHIKAWA YOSHIHIRO (JP) | 2016-09-15 | — | — | US | disclosed |
| US-20140206635-A1 | METAL-SALEN COMPLEX COMPOUND, LOCAL ANESTHETIC AND ANTINEOPLASTIC DRUG | IHI CORPORATION (JP) | 2014-07-24 | — | — | US | disclosed |
| US-20120029167-A1 | AUTO MAGNETIC METAL SALEN COMPLEX COMPOUND | YOSHIHIRO ISHIKAWA (JP) | 2012-02-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120029167-A1 | AUTO MAGNETIC METAL SALEN COMPLEX COMPOUND | SDHB, SDHA, SLC40A1 | PYGB 855/4885LGALS3 4550/4885LGALS8 4648/4885 |
| US-20140206635-A1 | METAL-SALEN COMPLEX COMPOUND, LOCAL ANESTHETIC AND ANTINEOPLASTIC DRUG | NCLN, KCNN2, NCSTN | PYGB 4266/4885LGALS3 4816/4885LGALS8 4536/4885 |
| US-10034851-B2 | Metal-salen complex compound, local anesthetic and antineoplastic drug | NCLN, KCNN2, NCSTN | PYGB 4266/4885LGALS3 4816/4885LGALS8 4536/4885 |
| US-20160263074-A1 | METAL-SALEN COMPLEX COMPOUND, LOCAL ANESTHETIC AND ANTINEOPLASTIC DRUG | NCLN, KCNN2, NCSTN | PYGB 4266/4885LGALS3 4816/4885LGALS8 4536/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.